I'm planning to submit a paper to a peer-reviewed journal for review. The paper will be focused on the use of AI and machine learning in drug development, with a focus on identifying potential biomarkers for disease progression. I'd like to include some specific examples from recent studies, including a study published in Nature Medicine last year that showed promising results with a new treatment for multiple sclerosis. However, I'm having trouble finding reliable information on the current status of the FDA's review process for these treatments. Can you tell me more about the current requirements and timeline for bringing these medications to market? Additionally, I'd like to know more about the role of patient engagement in this process - specifically, how do patients typically receive information about new treatments during clinical trials? I've also been looking at some data from a recent study on the use of wearable devices to track disease progression in patients with Type 1 diabetes. Can you provide me with some context on the current standard for data quality and validation in this field? Finally, I'd like to know more about the potential risks and benefits of using genomics to personalize treatment plans - what are some of the key challenges and limitations of this approach? Specifically, I'd like to know more about the work being done by Dr. Smith on the use of CRISPR-Cas9 to edit genes involved in disease progression. Can you provide me with a summary of his findings and recommendations for future research? The report will also include some background information on the history of gene editing technology, as well as an overview of the current regulatory framework for this area of research. I'd like to see at least 5 references cited in the paper, including a study published in Science last year that showed promising results with a new gene therapy approach for treating muscular dystrophy. However, the report will not include any specific information on the report's own methodology or data quality - I'm looking for guidance on how to improve my reporting and analysis of this topic.